2023-11-02 16:58:49 ET
- Puma Biotechnology press release ( NASDAQ: PBYI ): Q3 Non-GAAP EPS of $0.17 beats by $0.03 .
- Revenue of $56.1M (-1.8% Y/Y) misses by $1.85M .
-
Fourth Quarter and Full Year 2023 Financial Outlook
Fourth Quarter 2023
Full Year 2023
Product Revenue, Net
$56 million - $59 million
$206 million - $209 million
Royalty Revenue
$16 million - $19 million
$30 million - $32 million
Net Income
$13 million - $16 million
$22 million - $25 million
Gross to Net Adjustment
15.5% - 16.5%
17.5% - 18.0%
For further details see:
Puma Biotechnology reports mixed Q3 earnings; initiates Q4 and updates FY23 outlook